Payment overview · 2025
General Payments
$67.56
2 reported records · 2 companies
Healthcare provider profile · identity verified
Joel D Silverberg, MD
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism · BATON ROUGE, LA · NPI 1750308573
Verified facts
What the public records show
CMS Open Payments records show Joel D Silverberg, MD received $67.56 in general payments during 2025 across 2 reported records.
Ascensia Diabetes Care Us Inc. accounted for 64.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Ascensia Diabetes Care Us Inc. | Unresolved — no canonical attribution shown | $43.52 | 64.4% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $24.04 | 35.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $43.52 | 1 |
| Education | $24.04 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CRENESSITY Normalized: crenessity |
Drug | Neurocrine BioSciences, Inc. | $24.04 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 2494 | 611 |
| Ozempic | Semaglutide | 1069 | 183 |
| Atorvastatin Calcium | Atorvastatin Calcium | 859 | 248 |
| Metformin Hcl Er | Metformin Hcl | 719 | 205 |
| Jardiance | Empagliflozin | 580 | 160 |
| Synthroid | Levothyroxine Sodium | 536 | 130 |
| Hydrochlorothiazide | Hydrochlorothiazide | 422 | 124 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 420 | 123 |
| Losartan Potassium | Losartan Potassium | 390 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 371 | 98 |
| Alendronate Sodium | Alendronate Sodium | 331 | 103 |
| Metformin Hcl | Metformin Hcl | 313 | 91 |
| Pravastatin Sodium | Pravastatin Sodium | 278 | 84 |
| Gabapentin | Gabapentin | 238 | 62 |
| Novolog Flexpen | Insulin Aspart | 226 | 73 |
| Ezetimibe | Ezetimibe | 213 | 61 |
| Mounjaro | Tirzepatide | 191 | 28 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 174 | 75 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 171 | 57 |
| Novolog | Insulin Aspart | 158 | 40 |
| Lisinopril | Lisinopril | 153 | 48 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 153 | 42 |
| Methimazole | Methimazole | 145 | 37 |
| Glimepiride | Glimepiride | 132 | 41 |
| Testosterone Cypionate | Testosterone Cypionate | 125 | 32 |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 124 | 31 |
| Trulicity | Dulaglutide | 121 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 117 | 42 |
| Potassium Chloride | Potassium Chloride | 115 | 37 |
| Prednisone | Prednisone | 113 | 25 |
| Sertraline Hcl | Sertraline Hcl | 110 | 28 |
| Carvedilol | Carvedilol | 107 | 25 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 107 | 16 |
| Valsartan | Valsartan | 103 | 33 |
| Humalog Kwikpen U-100 | Insulin Lispro | 102 | 38 |
| Humalog | Insulin Lispro | 99 | 17 |
| Allopurinol | Allopurinol | 88 | 21 |
| Droplet Pen Needle | Pen Needle, Diabetic | 84 | 32 |
| Spironolactone | Spironolactone | 82 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 28 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 78 | 24 |
| Lovastatin | Lovastatin | 77 | 19 |
| Testosterone | Testosterone | 76 | 16 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 74 | 21 |
| Hydrocortisone | Hydrocortisone | 69 | 15 |
| Metoprolol Succinate | Metoprolol Succinate | 68 | 22 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 66 | 21 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 61 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 17 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 60 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 58 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 57 | 18 |
| Calcitriol | Calcitriol | 55 | 13 |
| Glipizide Er | Glipizide | 55 | 19 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 55 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 55 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 54 | 17 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 53 | 20 |
| Labetalol Hcl | Labetalol Hcl | 49 | 15 |
| Cinacalcet Hcl | Cinacalcet Hcl | 46 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 46 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 12 |
| Omeprazole | Omeprazole | 45 | 14 |
| Victoza 3-Pak | Liraglutide | 45 | 11 |
| Benazepril Hcl | Benazepril Hcl | 44 | 12 |
| Atenolol | Atenolol | 41 | 11 |
| Farxiga | Dapagliflozin Propanediol | 41 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 41 | 12 |
| Glipizide | Glipizide | 40 | 12 |
| Admelog | Insulin Lispro | 39 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 39 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 38 | suppressed |
| Lorazepam | Lorazepam | 38 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 35 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 35 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 34 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 33 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Omnipod Dash Pods (Gen 4) | Insulin Pump Cart,cont Inf,bt | 33 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 32 | suppressed |
| Admelog Solostar | Insulin Lispro | 31 | 13 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 31 | suppressed |
| Kerendia | Finerenone | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 28 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 28 | suppressed |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 27 | suppressed |
| Ramipril | Ramipril | 27 | suppressed |
| Cabergoline | Cabergoline | 26 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 24 | 17 |
| Raloxifene Hcl | Raloxifene Hcl | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 23 | suppressed |
| Humulin R U-500 | Insulin Regular, Human | 23 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 22 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 22 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 21 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Eliquis | Apixaban | 20 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 20 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Eplerenone | Eplerenone | 19 | suppressed |
| Furosemide | Furosemide | 19 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 19 | suppressed |
| Alprazolam | Alprazolam | 18 | suppressed |
| Gvoke Hypopen 2-Pack | Glucagon | 18 | 16 |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 18 | suppressed |
| Simvastatin | Simvastatin | 18 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 15 |
| Baqsimi | Glucagon | 15 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Genotropin | Somatropin | 15 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 15 | suppressed |
| Repaglinide | Repaglinide | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Droplet Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 14 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Demeclocycline Hcl | Demeclocycline Hcl | 13 | suppressed |
| Insulin Syringe | Syrge-Ndl,ins 0.3 Ml Half Mark | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Veo Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.56 · 2 records | Ascensia Diabetes Care Us Inc. | CRENESSITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error